Ropinirole Hydrochloride

盐酸罗匹尼罗

Report date: 2025/05/15 16:39:18
NME

Base Information

Drug NameRopinirole Hydrochloride
Drug Alias Name罗匹尼罗ropinirolropinirole盐酸罗平尼洛ropinirolum +[24] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsRestless Legs SyndromeHemiplegiaDyskinesias +[9] 
Global Approved IndicationsRestless Legs SyndromeParkinson Disease
Approved Indications in ChinaRestless Legs SyndromeParkinson Disease
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1996/07/08
Country/TerritoryCzechiaBelgiumBulgaria +[26] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcZein Bioteccnology Co Ltd
Inactive CompaniesUniversity of California IrvineGlaxosmithkline LlcTitan Pharmaceuticals Inc +[8] 
Active IndicationsRestless Legs SyndromeParkinson Disease
Inactive IndicationsHemiplegiaDyskinesiasHyperprolactinemia +[7] 

Other Information

ATC CodeN04BC04
Related LinksWikipediaDrugBankKEGG